Select Page

This is part III of my FCPA Rewards Pharma Series. Part I of the series can be viewed here, and part II of the series can be viewed here. This video focuses on the pharmaceutical and healthcare sector and will examine reward eligible schemes under the Dodd-Frank program. In particular, this video will examine pharma’s bribery of foreign regulatory officials, such as MOH, SSI, and FDA officials.



Andy Rickman is an SEC whistleblower attorney who has filed FCPA reward submissions for international clients residing in more than 50 different countries. He is based in Washington, DC where Dodd-Frank reward submissions are filed and the SEC is headquartered. Mr. Rickman offers a free consultation to anyone who would like to discuss whether he or she has a Dodd-Frank reward eligible case. Please feel free to contact him at